PT98202A - Processo para a preparacao de uma vacina contra a doenca de lyme, compreendendo uma quantidade dos principais antigenios contra b.burgdorferi - Google Patents

Processo para a preparacao de uma vacina contra a doenca de lyme, compreendendo uma quantidade dos principais antigenios contra b.burgdorferi

Info

Publication number
PT98202A
PT98202A PT98202A PT9820291A PT98202A PT 98202 A PT98202 A PT 98202A PT 98202 A PT98202 A PT 98202A PT 9820291 A PT9820291 A PT 9820291A PT 98202 A PT98202 A PT 98202A
Authority
PT
Portugal
Prior art keywords
burgdorferi
osp
lyme disease
comprehensing
mammal
Prior art date
Application number
PT98202A
Other languages
English (en)
Other versions
PT98202B (pt
Inventor
William Marshall Acree
Bonnie Lee Wallace
Hsien-Jue Steve Chu
Lloyd George Chavez
David Scott Sandblom
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of PT98202A publication Critical patent/PT98202A/pt
Publication of PT98202B publication Critical patent/PT98202B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
PT98202A 1990-07-06 1991-07-04 Processo para a preparacao de uma vacina contra a doenca de lyme, compreendendo uma quantidade dos principais antigenios contra b.burgdorferi PT98202B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54919090A 1990-07-06 1990-07-06

Publications (2)

Publication Number Publication Date
PT98202A true PT98202A (pt) 1992-05-29
PT98202B PT98202B (pt) 1999-02-26

Family

ID=24192007

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98202A PT98202B (pt) 1990-07-06 1991-07-04 Processo para a preparacao de uma vacina contra a doenca de lyme, compreendendo uma quantidade dos principais antigenios contra b.burgdorferi

Country Status (11)

Country Link
EP (2) EP0465204B1 (pt)
JP (1) JPH04297424A (pt)
AT (1) ATE196425T1 (pt)
AU (1) AU8014691A (pt)
CA (1) CA2046025A1 (pt)
DE (1) DE69132417T2 (pt)
DK (1) DK0465204T3 (pt)
ES (1) ES2149759T3 (pt)
GR (1) GR3034460T3 (pt)
IE (2) IE912303A1 (pt)
PT (1) PT98202B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4015911A1 (de) * 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
US5217872A (en) * 1990-02-27 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Method for detection of borrelia burgdorferi antigens
CA2057536C (en) * 1990-12-21 1999-10-26 John J. Dunn Cloning and expression of borrelia lipoproteins
US6221363B1 (en) * 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
EP0878545A3 (en) * 1991-08-15 1998-12-16 SMITHKLINE BEECHAM BIOLOGICALS s.a. OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines
US6676942B1 (en) 1991-08-15 2004-01-13 Smithkline Beecham Biologicals (S.A.) Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
DK0757556T3 (da) * 1994-04-11 2006-10-02 Wyeth Corp Borrelia Burgdorferi-bakterin
DE19629543C2 (de) * 1996-07-22 1999-02-11 Immuno Ag Immunassay zum Nachweis von anti-B. burgdorferi Antikörpern und Verfahren zur Serodiagnose bei Lyme Borreliose, diagnostische Mittel und Testkits zur Durchführung der Verfahren
US6368603B1 (en) * 1997-03-05 2002-04-09 Merial Limited Lyme combination compositions and uses
ES2270523T3 (es) * 1997-06-30 2007-04-01 The Administrators Of The Tulane Educational Fund Antigenos de superficie y proteinas utiles en composiciones para la diagnosis y prevencion de la enfermedad de lyme.
US6475492B1 (en) 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
WO2002016421A2 (en) 2000-08-18 2002-02-28 Research Foundation Of The State University Of New York Altered ospa of borrelia burgdorferi
JP2006515024A (ja) * 2003-01-29 2006-05-18 ファイザー・プロダクツ・インク Bordetellabronchisepticaに対するイヌワクチン
US20050202046A1 (en) * 2004-03-11 2005-09-15 Wyeth Canine vaccine for protection against ehrlichiosis
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
KR101192127B1 (ko) 2006-11-03 2012-10-17 쉐링-프라우 리미티드 개 라임병 백신
US9816991B2 (en) 2012-02-01 2017-11-14 Biopeptides Corporation Diagnostic peptides for lyme disease
WO2015085323A1 (en) 2013-12-06 2015-06-11 Biopeptides Corp. Peptides for diagnosing lyme disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US4372945A (en) 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
IL61904A (en) 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
US4721617A (en) 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
DE4015911A1 (de) * 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
DE3942728C1 (en) * 1989-12-22 1991-05-23 Mikrogen Molekularbiologische Entwicklungs-Gmbh, 8000 Muenchen, De New immunologically active proteins derived from Borelia burgdorferiensity polyethylene vessel and a high density polyethylene sealing cap - useful as vaccine and for quick accurate diagnosis of Borelia infections
WO1991013630A1 (en) * 1990-03-05 1991-09-19 The United States Of America, Represented By The Secretary, United States Department Of Commerce ANTIGENIC PROTEINS OF $i(BORRELIA BURGDORFERI)
JPH06501382A (ja) * 1990-06-15 1994-02-17 エール ユニバーシティ ライム病の予防および診断に用いる組成物および方法
WO1994004411A1 (de) 1992-08-21 1994-03-03 Baechtiger Rolf Kettengetriebe mit veränderlichem übersetzungsverhältnis und zahnkette

Also Published As

Publication number Publication date
EP0465204A2 (en) 1992-01-08
ATE196425T1 (de) 2000-10-15
DE69132417T2 (de) 2001-05-23
EP1016416A3 (en) 2002-10-23
IE20010565A1 (en) 2002-07-10
DE69132417D1 (de) 2000-10-26
DK0465204T3 (da) 2000-10-09
ES2149759T3 (es) 2000-11-16
AU8014691A (en) 1992-01-09
EP0465204A3 (en) 1993-03-10
GR3034460T3 (en) 2000-12-29
EP1016416A2 (en) 2000-07-05
CA2046025A1 (en) 1992-01-07
JPH04297424A (ja) 1992-10-21
IE912303A1 (en) 1992-01-15
PT98202B (pt) 1999-02-26
EP0465204B1 (en) 2000-09-20

Similar Documents

Publication Publication Date Title
PT98202A (pt) Processo para a preparacao de uma vacina contra a doenca de lyme, compreendendo uma quantidade dos principais antigenios contra b.burgdorferi
NO176004C (no) Fremgangsmåte ved fremstilling av vaksine mot hunde-coronavirus
DE69033728D1 (de) Impfstoffkonjugat
DE3071594D1 (en) Feline infectious peritonitis virus, its preparation and vaccines containing it
US4400472A (en) Novel rabies virus strain and a process for its preparation
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
ES8105930A1 (es) Procedimiento para la preparacion de vacunas de virus poli- valentes
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
ATE31116T1 (de) Diagnostisches antigen fuer traeger der durch pseudorabiesviren verursachten krankheit bei schweinen.
McFerran et al. Comparative studies with inactivated and attenuated vaccines for protection of fattening pigs
NZ226353A (en) Feline infectious peritonitus (fip) vaccine
KR920007636A (ko) 신규의 백신체
KR20050005470A (ko) Gp350 항원을 이용한 ebv 백신
Wisniewski et al. Effect of passive immunity of calves, acquired by colostrum, on the results of vaccination against foot-and-mouth disease
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.
GB2052983A (en) Vaccine for infectious bovine rhinotracheitis
DD160901A1 (de) Verfahren zur attenuierung des virus der transmissiblen gastroenteritis der schweine
NL8005083A (nl) Infectieuze bronchitis vaccins voor pluimvee en werkwijze voor het bereiden van dergelijke vaccins.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920214

FG3A Patent granted, date of granting

Effective date: 19981111

PC3A Transfer or assignment

Free format text: WYETH US

Effective date: 20030123

MM3A Annulment or lapse

Effective date: 20060511